APA (7th ed.) Citation

Rowe, D. L., Ozbay, T., Bender, L. M., & Nahta, R. (2008). Nordihydroguaiaretic acid, a cytotoxic insulin-like growth factor-I receptor/HER2 inhibitor in trastuzumab-resistant breast cancer. Molecular cancer therapeutics, 7(7), 1900. https://doi.org/10.1158/1535-7163.MCT-08-0012

Chicago Style (17th ed.) Citation

Rowe, Danica L., Tuba Ozbay, Laura M. Bender, and Rita Nahta. "Nordihydroguaiaretic Acid, a Cytotoxic Insulin-like Growth Factor-I Receptor/HER2 Inhibitor in Trastuzumab-resistant Breast Cancer." Molecular Cancer Therapeutics 7, no. 7 (2008): 1900. https://doi.org/10.1158/1535-7163.MCT-08-0012.

MLA (9th ed.) Citation

Rowe, Danica L., et al. "Nordihydroguaiaretic Acid, a Cytotoxic Insulin-like Growth Factor-I Receptor/HER2 Inhibitor in Trastuzumab-resistant Breast Cancer." Molecular Cancer Therapeutics, vol. 7, no. 7, 2008, p. 1900, https://doi.org/10.1158/1535-7163.MCT-08-0012.